# Title
Genetic O
variation O
at O
the O
CYP2C B-Gene
locus O
and O
its O
association O
with O
torsemide B-Chemical
biotransformation. O

# Abstract
In O
97 O
unselected O
volunteers O
and O
two O
additional O
homozygous O
carriers O
of O
CYP2C9(*)3, O
we O
investigated O
the O
oral O
clearance O
of O
torsemide B-Chemical
in O
relation O
to O
37 O
polymorphisms O
at O
the O
CYP2C B-Gene
gene O
locus. O
Torsemide B-Chemical
total O
oral O
clearance O
was O
linearly O
associated O
with O
the O
number O
of O
CYP2C9(*)3 O
alleles O
(geometric O
mean: O
59, O
40 O
and O
20 O
ml O
min O
in O
carriers O
of O
no, O
one O
and O
two O
alleles) O
and O
so O
were O
the O
methyl- O
and O
ring-hydroxylation O
but O
not O
the O
carboxylation O
clearance. O
Haplotypes O
including O
the O
CYP2C9(*)3 O
allele O
were O
similarly O
associated O
with O
the O
clearances O
but O
no O
other O
variant O
and O
no O
haplotype O
not O
including O
the O
CYP2C9(*)3 O
variant. O
The O
extended O
haplotype O
length O
(EHL) O
of O
the O
CYP2C9 B-Gene
haplotypes O
was O
positively O
associated O
with O
higher O
activity O
of O
the O
gene O
product. O
Torsemide B-Chemical
total O
oral O
clearance O
was O
predictable O
with O
r(2)=82.1% O
using O
plasma O
concentrations O
at O
0.5, O
1, O
2 O
and O
24 O
h. O
In O
conclusion, O
torsemide's O
biotransformation O
strongly O
depended O
on O
the O
CYP2C9(*)3 O
variant O
but O
no O
other. O
Higher O
clearance O
CYP2C9 B-Gene
haplotypes O
appear O
to O
be O
evolutionarily O
selected. O